Sign in Pull a receipt

LITS

Lite Strategy, Inc.

Healthcare · Biotechnology

$86.96 sample

+0.02 (+0.02%) 1D

Market cap

$143.8B

Price as of

2026-10-29

Latest filing

8-K · 2026-10-23

Alerts

8

Price$86.96 +18.81% 3M daily closessample

88.0772.10

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 23SECDEF 14A filed
Oct 20INSInsider sell: Chief Executive Officer
Oct 12INSInsider sell: 10% owner
Oct 06INSInsider buy: Chief Financial Officer
Sep 28INSInsider buy: EVP, Operations
Sep 21INSInsider buy: EVP, Operations
Sep 11INSInsider sell: Chief Executive Officer
Sep 02INSInsider sell: 10% owner

Sign up to see the real LITS record →

Company facts

SEC EDGAR registration

Name: Lite Strategy, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +2sample, -100 to +100
Reporting currency: USD

Who is positioning in LITS

sample

Insiders: 10 insider transactions over 90 days, net selling, $648.2M
Congress: 5 members traded over 90 days
Institutions · 13F: 16 funds hold $2.1B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$7.5B +14.1% y/y

Q4 2024Q3 2026

Inventory$4.8B +22.7% y/y

Q4 2024Q3 2026

Accounts receivable$3.4B +5.6% y/y

Q4 2024Q3 2026

Total debt$9.4B +9.9% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $106.0B +0.9% 3M
Sample peer B: $98.1B -3.3% 3M
Sample peer C: $114.2B -3.9% 3M
Sample peer D: $128.8B +7.0% 3M
Sample peer E: $21.3B +10.5% 3M